Sleep disturbance in patients with an implantable cardioverter defibrillator: Prevalence, predictors and impact on health status

M. Habibović*, L. Mudde, S. S. Pedersen, D. Schoormans, J. Widdershoven, J. Denollet

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

111 Downloads (Pure)

Abstract

Background: Sleep disturbances are highly prevalent in patients with cardiac diseases and associated with poor health outcomes. However, little is known about sleep disturbance in patients with an implantable cardioverter defibrillator. Aims: We examined the prevalence and predictors of sleep disturbance and the impact on perceived health status in a Dutch cohort of implantable cardioverter defibrillator patients. Methods: Patients (n=195) enrolled in the Web-based distress program for implantable cardioverter defibrillator patients (WEBCARE) trial completed questionnaires at the time of implantable cardioverter defibrillator implantation, three, six and 12 months afterwards. Sleep disturbance was assessed with the corresponding item #3 of the Patient Health Questionnaire 9. Results: At baseline, 67% (n=130) reported sleep disturbance (cut off ≥1). One year later, the prevalence was 57% (n=112). Younger age (odds ratio=0.96, 95% confidence interval 0.92–0.99; p=0.012) and high negative affectivity/low social inhibition (odds ratio=4.47, 95% confidence interval 1.52–13.17; p=0.007) were associated with sleep disturbance at 12 months in adjusted analyses. Sleep disturbance was not associated with health status at 12 months. Charlson Comorbidity Index, anxiety, Type D personality and high negative affectivity/low social inhibition were associated with impaired health status at follow-up. Conclusions: Sleep disturbance was highly prevalent in patients with an implantable cardioverter defibrillator. Younger age and high negative affectivity predicted sleep disturbance 12 months post-implantation independent of other demographic, clinical, intervention and psychological covariates. Sleep disturbance was not associated with impaired health status at the 12-month follow-up.

Original languageEnglish
JournalEuropean Journal of Cardiovascular Nursing
Volume17
Issue number5
Pages (from-to)390-398
ISSN1474-5151
DOIs
Publication statusPublished - 1. Jun 2018

Fingerprint

Implantable Defibrillators
Type D Personality
Odds Ratio
Confidence Intervals
Health
Comorbidity

Keywords

  • Journal Article

Cite this

@article{803adfdb50104adfa13d0452296ac29c,
title = "Sleep disturbance in patients with an implantable cardioverter defibrillator: Prevalence, predictors and impact on health status",
abstract = "Background: Sleep disturbances are highly prevalent in patients with cardiac diseases and associated with poor health outcomes. However, little is known about sleep disturbance in patients with an implantable cardioverter defibrillator. Aims: We examined the prevalence and predictors of sleep disturbance and the impact on perceived health status in a Dutch cohort of implantable cardioverter defibrillator patients. Methods: Patients (n=195) enrolled in the Web-based distress program for implantable cardioverter defibrillator patients (WEBCARE) trial completed questionnaires at the time of implantable cardioverter defibrillator implantation, three, six and 12 months afterwards. Sleep disturbance was assessed with the corresponding item #3 of the Patient Health Questionnaire 9. Results: At baseline, 67{\%} (n=130) reported sleep disturbance (cut off ≥1). One year later, the prevalence was 57{\%} (n=112). Younger age (odds ratio=0.96, 95{\%} confidence interval 0.92–0.99; p=0.012) and high negative affectivity/low social inhibition (odds ratio=4.47, 95{\%} confidence interval 1.52–13.17; p=0.007) were associated with sleep disturbance at 12 months in adjusted analyses. Sleep disturbance was not associated with health status at 12 months. Charlson Comorbidity Index, anxiety, Type D personality and high negative affectivity/low social inhibition were associated with impaired health status at follow-up. Conclusions: Sleep disturbance was highly prevalent in patients with an implantable cardioverter defibrillator. Younger age and high negative affectivity predicted sleep disturbance 12 months post-implantation independent of other demographic, clinical, intervention and psychological covariates. Sleep disturbance was not associated with impaired health status at the 12-month follow-up.",
keywords = "Journal Article",
author = "M. Habibović and L. Mudde and Pedersen, {S. S.} and D. Schoormans and J. Widdershoven and J. Denollet",
year = "2018",
month = "6",
day = "1",
doi = "10.1177/1474515117748931",
language = "English",
volume = "17",
pages = "390--398",
journal = "European Journal of Cardiovascular Nursing",
issn = "1474-5151",
publisher = "SAGE Publications",
number = "5",

}

Sleep disturbance in patients with an implantable cardioverter defibrillator : Prevalence, predictors and impact on health status. / Habibović, M.; Mudde, L.; Pedersen, S. S.; Schoormans, D.; Widdershoven, J.; Denollet, J.

In: European Journal of Cardiovascular Nursing, Vol. 17, No. 5, 01.06.2018, p. 390-398.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Sleep disturbance in patients with an implantable cardioverter defibrillator

T2 - Prevalence, predictors and impact on health status

AU - Habibović, M.

AU - Mudde, L.

AU - Pedersen, S. S.

AU - Schoormans, D.

AU - Widdershoven, J.

AU - Denollet, J.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Background: Sleep disturbances are highly prevalent in patients with cardiac diseases and associated with poor health outcomes. However, little is known about sleep disturbance in patients with an implantable cardioverter defibrillator. Aims: We examined the prevalence and predictors of sleep disturbance and the impact on perceived health status in a Dutch cohort of implantable cardioverter defibrillator patients. Methods: Patients (n=195) enrolled in the Web-based distress program for implantable cardioverter defibrillator patients (WEBCARE) trial completed questionnaires at the time of implantable cardioverter defibrillator implantation, three, six and 12 months afterwards. Sleep disturbance was assessed with the corresponding item #3 of the Patient Health Questionnaire 9. Results: At baseline, 67% (n=130) reported sleep disturbance (cut off ≥1). One year later, the prevalence was 57% (n=112). Younger age (odds ratio=0.96, 95% confidence interval 0.92–0.99; p=0.012) and high negative affectivity/low social inhibition (odds ratio=4.47, 95% confidence interval 1.52–13.17; p=0.007) were associated with sleep disturbance at 12 months in adjusted analyses. Sleep disturbance was not associated with health status at 12 months. Charlson Comorbidity Index, anxiety, Type D personality and high negative affectivity/low social inhibition were associated with impaired health status at follow-up. Conclusions: Sleep disturbance was highly prevalent in patients with an implantable cardioverter defibrillator. Younger age and high negative affectivity predicted sleep disturbance 12 months post-implantation independent of other demographic, clinical, intervention and psychological covariates. Sleep disturbance was not associated with impaired health status at the 12-month follow-up.

AB - Background: Sleep disturbances are highly prevalent in patients with cardiac diseases and associated with poor health outcomes. However, little is known about sleep disturbance in patients with an implantable cardioverter defibrillator. Aims: We examined the prevalence and predictors of sleep disturbance and the impact on perceived health status in a Dutch cohort of implantable cardioverter defibrillator patients. Methods: Patients (n=195) enrolled in the Web-based distress program for implantable cardioverter defibrillator patients (WEBCARE) trial completed questionnaires at the time of implantable cardioverter defibrillator implantation, three, six and 12 months afterwards. Sleep disturbance was assessed with the corresponding item #3 of the Patient Health Questionnaire 9. Results: At baseline, 67% (n=130) reported sleep disturbance (cut off ≥1). One year later, the prevalence was 57% (n=112). Younger age (odds ratio=0.96, 95% confidence interval 0.92–0.99; p=0.012) and high negative affectivity/low social inhibition (odds ratio=4.47, 95% confidence interval 1.52–13.17; p=0.007) were associated with sleep disturbance at 12 months in adjusted analyses. Sleep disturbance was not associated with health status at 12 months. Charlson Comorbidity Index, anxiety, Type D personality and high negative affectivity/low social inhibition were associated with impaired health status at follow-up. Conclusions: Sleep disturbance was highly prevalent in patients with an implantable cardioverter defibrillator. Younger age and high negative affectivity predicted sleep disturbance 12 months post-implantation independent of other demographic, clinical, intervention and psychological covariates. Sleep disturbance was not associated with impaired health status at the 12-month follow-up.

KW - Journal Article

U2 - 10.1177/1474515117748931

DO - 10.1177/1474515117748931

M3 - Journal article

C2 - 29260886

VL - 17

SP - 390

EP - 398

JO - European Journal of Cardiovascular Nursing

JF - European Journal of Cardiovascular Nursing

SN - 1474-5151

IS - 5

ER -